CCChristopher M. Callahan

Christopher M. Callahan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christopher M. Callahan has a total of 92 co-authors. Here are the top co-authors by number of shared publications:

  • Hugh C. Hendrie

    Indiana University Center for Aging Research, Indianapolis, Indiana; Regenstrief Institute, Inc, Indianapolis, Indiana; Department of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, Indiana; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana

    7 shared publications
  • Malaz A. Boustani

    Center for Aging Research, Indiana University, Indianapolis, Indiana

    4 shared publications
  • Malaz Boustani

    Indiana University Center for Aging Research, Indianapolis, IN, USA

    4 shared publications
  • Steven R. Counsell

    Indiana University Center for Aging Research Indiana University School of Medicine Indianapolis Indiana

    4 shared publications
  • Anthony J. Perkins

    Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, USA

    3 shared publications
  • Hugh C. Hendrie

    Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA

    3 shared publications

Latest Publications

  • Novel Markers of Angiogenesis in the Setting of Cognitive Impairment and Dementia

    by Christopher M Callahan, Liana G Apostolova, Sujuan Gao, Shannon L Risacher, Jamie Case, Andrew J Saykin, Kathleen A Lane, Cecily G Swinford, Mervin C Yoder

    Background: Aberrant angiogenesis may play a role in the development of Alzheimer’s disease and related dementia. Objective: To explore the relationship between angiogenesis activity and evidence of neurodegeneration among older adults. Methods: Cross-sectional study of 49 older adults clinically characterized as cognitively normal, mild cognitive impairment, or early Alzheimer’s disease. In addition to neuroimaging, we completed assays on peripheral blood, including: vascular endothelial growth factor, tumor necrosis factor, fibroblast growth factor, and amyloid-β peptide 40. We used advanced polychromatic flow cytometry to phenotype circulating mononuclear cells to assess angiogenesis activity. Results: Although we documented differences in cognitive performance, structural changes on neuroimaging, and burden of amyloid and tau on positron emission tomography, angiogenesis activity did not vary by group. Interestingly, VEGF levels were shown to be increased among subjects with mild cognitive impairment. In ANCOVA models controlling for age, sex, intracranial volume, and monocyte subpopulations, angiogenesis activity was correlated with increased white matter hyperintensities. Conclusion: We demonstrate a significant association between angiogenesis activity and cerebrovascular disease. To better understand the potential of angiogenesis as an intervention target, longitudinal studies are needed.


  • State of Science: Bridging the Science‐Practice Gap in Aging, Dementia and Mental Health

    by Christopher M. Callahan, Daniel R. Bateman, Sophia Wang, Malaz A. Boustani

    The workforce available to care for older adults has not kept pace with the need. In response to workforce limitations and the growing complexity of healthcare, scientists have tested new models of care that redesign clinical practice. This article describes why new models of care in aging, dementia, and mental health diffuse inadequately into the healthcare systems and communities where they might benefit older adults. We review a general framework for the diffusion of innovations and highlight the importance of other features of innovations that deter or facilitate diffusion. Although scientists often focus on generating evidence‐based innovations, end‐users apply their own criteria to determine an innovation's value. In 1962, Rogers suggested six features of an innovation that facilitate or deter diffusion suggested: relative advantage, compatibility with the existing environment, ease or difficulty of implementation, trial‐ability or ability to “test drive”, adaptability, and observed effectiveness. We describe examples of models of care in aging, dementia and mental health that enjoy a modicum of diffusion into practice and place the features of these models in the context of deterrents and facilitators for diffusion. Developers of models of care in aging, dementia, and mental health typically fail to incorporate the complexities of health systems, the barriers to diffusion, and the role of emotion into design considerations of new models. We describe agile implementation as a strategy to facilitate the speed and scale of diffusion in the setting of complex adaptive systems, social networks, and dynamic macroenvironments.


  • Alzheimer's Disease: Individuals, Dyads, Communities, and Costs

    by Christopher M. Callahan

    Alzheimer's disease and related dementias ( ADRD ) affect over 5 million Americans. Over a typical disease course of 5–10 years, family caregivers provide the majority of the day‐to‐day hands‐on on care for persons with dementia. Most caregivers enter this complex role with little training and inadequate household resources and they are tasked to navigate a fragmented health care system as well as a patchwork of community services. Our nation can and should do more to help family caregivers provide care in the home to their loved ones who suffer from dementia. We will all benefit if we design and implement a better system of care for persons with dementia. We will benefit financially as a nation, we will benefit morally as a community, and in case we have forgotten, we stand to benefit ourselves as we age and face our own aging brain. Building a system of care requires excellent science and engineering, but we also need creative approaches that design systems of care that are available nationwide because they are scalable and affordable. Most importantly, families need our help now. We need to move faster.


  • Correlation Between Caregiver Reports of Physical Function and Performance-based Measures in a Cohort of Older Adults With Alzheimer Disease

    by Brittany L. Bs Bernard, Lauren E. Bracey, Kathleen A. Lane, Denisha Y. Aas Ferguson, Michael A. LaMantia, Sujuan Gao, Douglas K. Miller, Christopher M. Callahan

    The objectives of this report are to determine the association between performance-based measures of physical function with caregiver reports of physical function in older adults with Alzheimer disease (AD) and to examine whether those associations vary by the level of patients’ cognitive functioning. Subjects included 180 patient-caregiver dyads who are enrolled in a clinical trial testing the impact of an occupational therapy intervention plus guideline-level care to delay functional decline among older adults with AD. The primary caregiver-reported measure is the Alzheimer’s Disease Cooperative Study Group Activities of Daily Living Inventory (ADCS-ADL). Performance-based measures include the Short Physical Performance Battery and the Short Portable Sarcopenia Measure. Analysis of covariance (ANCOVA) models were used to determine the associations of each physical performance measure with ADCS-ADL, adjusting for cognition function and other covariates. We found significant correlations between caregiver reports and observed performance-based measures across all levels of cognitive function, with patients in the lowest cognitive group showing the highest correlation. These findings support the use of proxy reports to assess physical function among older adults with AD.


  • Transitions in Care in a Nationally Representative Sample of Older Americans with Dementia

    by Christopher M. Callahan, Wanzhu Tu, Kathleen T. Unroe, Michael A. LaMantia, Timothy E. Stump, Daniel O. Clark

    Objectives: To describe transitions in care for older adults with dementia identified from a nationally representative cohort and to describe transition rates in those with more‐severe levels of cognitive and functional impairment. Design: Longitudinal cohort study. Setting: Health and Retirement Study ( HRS ). Participants: HRS respondents aged 65 and older whose survey data were linked with Medicare claims from 1999 to 2008 (N = 16,186). Measurements: Transitions in care between home, home with formal services, hospital, and nursing facility care; cognitive function; activities of daily living; and mortality. Results: The 3,447 (21.3%) HRS subjects who were ever diagnosed with dementia experienced frequent transitions. Of subjects transitioning from a hospital stay, 52.2% returned home without home care services, and 33.8% transitioned to a nursing facility. Of subjects transitioning from a nursing facility, 59.2% transitioned to the hospital, and 25.3% returned home without services. There were 2,139 transitions to death, and 58.7% of HRS subjects with dementia died at home. Even in persons with moderate to severe dementia, multiple transitions in care were documented, including transitions from the hospital to home and back to the hospital. Conclusion: In this nationally representative sample of older adults, subjects diagnosed with dementia experience frequent transitions. Persons with dementia who are cared for at home and who transition back to home often have moderate to severe impairments in function and cognition.


  • Errors in Self-Reports of Health Services Use

    by Christopher M. Callahan, Wanzhu Tu, Timothy E. Ma Stump, Daniel O. Clark, Kathleen T. Md Unroe, Hugh C. MB Hendrie

    Background: Most Alzheimer disease clinical trials that compare the use of health services rely on reports of caregivers. The goal of this study was to assess the accuracy of self-reports among older adults with Alzheimer disease and their caregiver proxy respondents. This issue is particularly relevant to Alzheimer disease clinical trials because inaccuracy can lead both to loss of power and increased bias in study outcomes. Methods: We compared respondent accuracy in reporting any use and in reporting the frequency of use with actual utilization data as documented in a comprehensive database. We next simulated the impact of underreporting and overreporting on sample size estimates and treatment effect bias for clinical trials comparing utilization between experimental groups. Results: Respondents self-reports have a poor level of accuracy with κ-values often below 0.5. Respondents tend to underreport use even for rare events such as hospitalizations and nursing home stays. In analyses simulating underreporting and overreporting of varying magnitude, we found that errors in self-reports can increase the required sample size by 15% to 30%. In addition, bias in the reported treatment effect ranged from 3% to 18% due to both underreporting and overreporting errors. Conclusions: Use of self-report data in clinical trials of Alzheimer disease treatments may inflate sample size needs. Even when adequate power is achieved by increasing sample size, reporting errors can result in a biased estimate of the true effect size of the intervention.


  • Open Access

    Use of a multiparty web based videoconference support group for family caregivers: Innovative practice

    by Mary Guerriero Austrom, Kristin N Geros, Kimberly Hemmerlein, Siobhan M McGuire, Sujuan Gao, Steven A Brown, Christopher M Callahan, Daniel O Clark

    This article describes a pilot of a weekly web based videoconference support group for five caregivers of persons with dementia. All participants reported positive views of the group and videoconference medium. Improvements in caregiver anxiety, depression, and physical health scores were observed. Depression scores remained the same with difficulties experienced by the caregiver increasing slightly. Self-efficacy for controlling upsetting thoughts and responding to disruptive behavior improved but worsened slightly for obtaining respite. We concluded that web based support was a positive experience for caregivers, providing them with an acceptable, feasible, low-cost technological alternative to in person support that reduced barriers to attendance by being available in homes.


  • Open Access

    The Indiana University Cognitive Health Outcomes Investigation of the Comparative Effectiveness of dementia screening (CHOICE) study: study protocol for a randomized controlled trial

    by Nicole R Fowler, Amanda Harrawood, Amie Frame, Anthony J Perkins, Sujuan Gao, Christopher M Callahan, Greg A Sachs, Dustin D French, Malaz A Boustani

    Dementia affects over 4 million people in the US and is frequently unrecognized and underdiagnosed in primary care. Routine dementia screening in primary care is not recommended by the US Preventive Services Task Force due to lack of empirical data on the benefits and harms of screening. This trial seeks to fill this gap and contribute information about the benefits, harms, and costs of routine screening for dementia in primary care.


  • The complexities of comorbidity in dementia

    by Christopher M. Callahan, Cathy C. Schubert